Brennan Hawken

Jul 17, 2026

On Jul 17, 2026, MS was given a Outperform rating by Brennan Hawken, with a target price of 250. The stock traded sideways with a -2.10% move, keeping the bullish thesis unresolved.

Jul 13, 2026

On Jul 13, 2026, Brennan Hawken published a Outperform outlook on OWL, with a target of 11. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 9.35.

Jul 13, 2026

On Jul 13, 2026, Brennan Hawken reaffirmed KKR with a Outperform rating, targeting 112. Market indecision has kept the 112 target in a holding pattern.

Jul 13, 2026

TPG was rated Outperform by Brennan Hawken on Jul 13, 2026, with a price objective of 50. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Jul 13, 2026

On Jul 13, 2026, Brennan Hawken initiated coverage on STEP with a Outperform rating and target of 50. Neutral price movement of -1.31% leaves room for interpretation.

May 22, 2026

Brennan Hawken rated HLNE as Outperform on May 22, 2026, setting a price target of 102. The stock has underperformed, dropping 6.33% despite the bullish target of 102.

Apr 22, 2026

On Apr 22, 2026, Brennan Hawken published a Outperform outlook on IBKR, with a target of 93. Shares gained 17.37%, underscoring the accuracy of the bullish outlook toward 93.

Apr 10, 2026

On Apr 10, 2026, Brennan Hawken reaffirmed IVZ with a Outperform rating, targeting 28. The recommendation was supported by strong follow-through as the stock rose from 29.66 to 29.66.

Apr 06, 2026

NTRS was rated Outperform by Brennan Hawken on Apr 06, 2026, with a price objective of 168. A bullish response from the market helped close the gap of -14.78 to the target.

Mar 24, 2026

On Mar 24, 2026, Brennan Hawken initiated coverage on CG with a Outperform rating and target of 58. The Buy call has yet to be validated as shares remain 13.26 away from the target.

Mar 24, 2026

Brennan Hawken issued a Outperform recommendation for BX on Mar 24, 2026, price target set at 126. Investors following the Buy call captured upside momentum, with shares now at 123.59.

Jan 29, 2026

On Jan 29, 2026, HLI was evaluated by Brennan Hawken, who gave a Outperform rating and target of 211. Investors saw limited payoff as shares fell short of the 211 target.

Oct 03, 2025

Brennan Hawken rated PJT as Outperform on Oct 03, 2025, setting a price target of 205. The stock has underperformed, dropping 8.43% despite the bullish target of 205.

Oct 03, 2025

LPLA received a Outperform rating from Brennan Hawken on Oct 03, 2025, aiming for 365. Price action was muted, as shares hovered around 327.96 despite the bullish outlook.

Oct 03, 2025

Brennan Hawken on Oct 03, 2025 assigned JHG a Outperform rating, with a price target of 52. The Buy call aligned well with market performance, producing a gain of 13.85%.

Oct 03, 2025

BK was rated Outperform by Brennan Hawken on Oct 03, 2025, with a price objective of 125. A bullish response from the market helped close the gap of -16.91 to the target.

Oct 03, 2025

On Oct 03, 2025, Brennan Hawken initiated coverage on BEN with a Outperform rating and target of 26. The stock’s climb of 35.42% since the call highlights the foresight in the rating.

Oct 03, 2025

Brennan Hawken issued a Outperform recommendation for STT on Oct 03, 2025, price target set at 130. Investors following the Buy call captured upside momentum, with shares now at 182.58.